EFFECT OF DIFFERENT FORMULATIONS OF ORAL CONTRACEPTIVE AGENTS ON LIPIDS AND CARBOHYDRATES METABOLISM IN NORMAL WOMEN AND WOMEN WITH PCOS
Main Article Content
Keywords
Polycystic ovary syndrome, oral contraceptive pills, levonorgestrel, drospirenone, insulin resistance, lipid metabolism, HOMA-IR
Abstract
Background
Oral contraceptive pills (OCPs) are frequently prescribed for menstrual cycle regulation and birth control, especially for women suffering from polycystic ovary syndrome (PCOS). While OCPs are effective in managing reproductive symptoms, the type of progestin used alters metabolic health in varying degrees. Because PCOS is characterized by an insulin resistant state along with lipid abnormality, it is important to study the metabolic implications of various contraceptive options in this population. In this study when comparing the two formulations ethinylestradiol and drospirenone versus ethinylestradiol and levonorgestrel, focus will be on lipid and carbohydrate metabolism on normal and PCOS women.
Methods
This study was conducted at Kuwait Teaching Hospital, Peshawar, in January 2024 as a comparative cross-sectional study. Out of the total 93 women, 93 were enrolled and grouped based on OCP type and clinical status. Blood samples were collected after fasting for lipid profile, glucose, insulin, HbA1c, and HOMA-IR. Data analysis was performed using SPSS version 25 and significance was set at p < 0.05.
Results
Among the groups, women with PCOS using levonorgestrel contraceptive OCPs exhibited the most pronounced increase in total cholesterol, LDL levels, fasting insulin, and HOMA-IR. Androgens’ effect on lipids was more favorable. Insulin resistance increased the least with drospirenone. Normal women on drospirenone had the least amount of metabolic changes relative to the other women.
Conclusion
OCPs containing drospirenone appears to affect metabolic parameters more positively compared to those containing levonorgestrel, particularly in patients suffering from PCOS. This emphasizes the need to tailor contraceptive methods to women’s specific needs and profile combining both endocrinology and metabolism.
References
2. Wang, A., et al., The effectiveness of metformin, oral contraceptives, and lifestyle modification in improving the metabolism of overweight women with polycystic ovary syndrome: a network meta-analysis. Endocrine, 2019. 64: p. 220-232.
3. Chernukha, G., et al., A differential approach to the administration of combined oral contraceptives in polycystic ovary syndrome. Obstetrics and Gynecology, 2019(7): p. 56-62.
4. Oguz, S.H. and B.O. Yildiz, An update on contraception in polycystic ovary syndrome. Endocrinology and Metabolism, 2021. 36(2): p. 296-311.
5. Amiri, M., et al., Effects of oral contraceptives on serum concentrations of adipokines and adiposity indices of women with polycystic ovary syndrome: a randomized controlled trial. Journal of Endocrinological Investigation, 2021. 44: p. 567-580.
6. Sadeghi, H.M., et al., Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. International journal of molecular sciences, 2022. 23(2): p. 583.
7. Kumarendran, B., et al., Polycystic ovary syndrome, combined oral contraceptives, and the risk of dysglycemia: a population-based cohort study with a nested pharmacoepidemiological case-control study. Diabetes care, 2021. 44(12): p. 2758-2766.
8. Khanage, S.G., T.Y. Subhash, and I.R. Bhaiyyasaheb, Herbal drugs for the treatment of polycystic ovary syndrome (PCOS) and its complications. Pharm. Res, 2019. 2(1): p. 5-13.
9. Witchel, S.F., S.E. Oberfield, and A.S. Peña, Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. Journal of the Endocrine Society, 2019. 3(8): p. 1545-1573.
10. Zeng, L.-H., et al., Polycystic ovary syndrome: a disorder of reproductive age, its pathogenesis, and a discussion on the emerging role of herbal remedies. Frontiers in Pharmacology, 2022. 13: p. 874914.
11. Cignarella, A., et al., Pharmacological approaches to controlling cardiometabolic risk in women with PCOS. International journal of molecular sciences, 2020. 21(24): p. 9554.
12. Sangaraju, S.L., et al., Cardio-metabolic disease and polycystic ovarian syndrome (PCOS): a narrative review. Cureus, 2022. 14(5).
13. Tehrani, F.R. and M. Amiri, Polycystic ovary syndrome in adolescents: challenges in diagnosis and treatment. International journal of endocrinology and metabolism, 2019. 17(3): p. e91554.
14. Barrea, L., et al., Adherence to the mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS). Nutrients, 2019. 11(10): p. 2278.
15. Papadakis, G., et al., Tailoring treatment for PCOS phenotypes. Expert Review of Endocrinology & Metabolism, 2021. 16(1): p. 9-18.
16. Kancherla, H., et al., Diagnosis and Treatment of Polycystic Ovary Syndrome (PCOS)-A Comparative Review. Infertility. 73: p. 75.
17. Calcaterra, V., et al., Polycystic ovary syndrome in insulin-resistant adolescents with obesity: the role of nutrition therapy and food supplements as a strategy to protect fertility. Nutrients, 2021. 13(6): p. 1848.
18. Wang, J., et al., Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. Life sciences, 2019. 236: p. 116940.
19. Li, Y., et al., Comparing the individual effects of metformin and rosiglitazone and their combination in obese women with polycystic ovary syndrome: a randomized controlled trial. Fertility and sterility, 2020. 113(1): p. 197-204.
20. Abdalla, M.A., et al., A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome. Therapeutic advances in endocrinology and metabolism, 2020. 11: p. 2042018820938305.
21. Lim, S.S., et al., Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews, 2019(3).
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Aqsa Latif
Senior Registrar, Department of Obstetrics and Gynaecology, Peshawar Medical College, Peshawar, Pakistan
Dr Salman Khan
Associate Professor, Department of Medicine, MMMTH, Gomal Medical College, Dera Ismail Khan, Pakistan
Dr Nusrat Fozia Pathan
Associate Professor, Department of Obstetrics Gynaecology, Khairpur Medical College,
Khairpur Mir's, Pakistan
Dr Sana Mukhtiar
House Officer, Department of Medicine, Peshawar Medical College, Kuwait Teaching
Hospital, Peshawar, Pakistan
Dr Bushra Noor Khuhro
Associate Professor, Department of Obstetrics and Gynaecology, Lady Willingdon Hospital, Khairpur Medical College, Khairpur, Pakistan
Dr Muhammad Rafique Tagar
Associate Professor, Department of Biochemistry, Bibi Aseefa Dental College,
SMBB Medical University, Larkana, Pakistan